Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > --NONEWS ON INSIDER BUYING---

<< Previous

Bullboard Posts

Next >>

Comment by Joeking123on Jun 22, 2020 8:08pm

66 Views

Post# 31178899

RE:RE:--NONEWS ON INSIDER BUYING---

Nice account created yesterday

ScumbagsGalore wrote:

threefiftynine wrote:

Is a good thing as the share price would rocket before it closes and we just cant have that now can we ?

Can't believe there are people still pumping this piece of krap. This company is front which has no actual business operations in Canada beyond a mailing address for a law office in downtown Toronto. Other than that its just a research lab in some Israeli industrial park that has never accomplished a damn thing in all their existence and never will. The stock ran to $.25 on a pump and dump play and that's all she wrote. Give it up.